Evidence map›Paper›PMID 26044814›Full record

ArticleTrials2015

Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platform.

Shaun Treweek, Doug G Altman, Peter Bower, Marion Campbell, Iain Chalmers, Seonaidh Cotton, Peter Craig, David Crosby, Peter Davidson, Declan Devane and 21 more

Abstract readConference Proceedings
In one paragraph

Article in Trials, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Shaun TreweekHealth Services Research Unit, University of Aberdeen, Aberdeen, AB25 2ZD, UK. streweek@mac.com.
Doug G AltmanCentre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Nuffield Orthopaedics Centre, Windmill Road, Oxford, OX3 7LD, UK. doug.altman@csm.ox.ac.uk.
Peter BowerMedical Research Council North West Hub for Trials Methodology Research, Manchester Academic Health Science Centre, Centre for Primary Care, University of Manchester, Oxford Road, Manchester, M13 9PL, UK. peter.bower@manchester.ac.uk.
Marion CampbellHealth Services Research Unit, University of Aberdeen, Aberdeen, AB25 2ZD, UK. m.k.campbell@abdn.ac.uk.
Iain ChalmersJames Lind Initiative, Oxford, UK. IChalmers@jameslindlibrary.org.
Seonaidh CottonHealth Services Research Unit, University of Aberdeen, Aberdeen, AB25 2ZD, UK. s.c.cotton@abdn.ac.uk.
Peter CraigMRC/CSO Social and Public Health Sciences Unit, University of Glasgow, 200 Renfield Street, Glasgow, G2 3QB, UK. peter.craig@glasgow.ac.uk.
David CrosbyMedical Research Council, Methodology Research Programme (MRC MRP), London, UK. david.crosby@headoffice.mrc.ac.uk.
Peter DavidsonConsultant in Public Health and Head of Health Technology Assessment, National Institute for Health Research, Evaluation, Trials, and Studies Coordinating Centre, University of Southampton, Alpha House, Enterprise Road, Southampton, SO16 7NS, UK. P.Davidson@soton.ac.uk.
Declan DevaneSchool of Nursing and Midwifery, National University of Ireland Galway, University Road, Galway, Ireland. declan.devane@nuigalway.ie.
Lelia DuleyNottingham Clinical Trials Unit (NCTU), Nottingham Health Science Partners, C Floor, South Block, Queens Medical Centre, Derby Road, Nottingham, NG7 2UH, UK. Lelia.Duley@nottingham.ac.uk.
Janet DunnWarwick Medical School, The University of Warwick, Coventry, CV4 7AL, UK. J.A.Dunn@warwick.ac.uk.
Diana ElbourneLondon School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. diana.elbourne@lshtm.ac.uk.
Barbara FarrellNational Perinatal Epidemiology Unit, University of Oxford, Oxford, UK. barbara.farrell@npeu.ox.ac.uk.
Carrol GambleNorth West Hub for Trials Methodology Research, University of Liverpool, 1st floor Duncan Building, Daulby Street, Liverpool, L69 3GA, UK. C.Gamble@liverpool.ac.uk.
Katie GilliesHealth Services Research Unit, University of Aberdeen, Aberdeen, AB25 2ZD, UK. k.gillies@abdn.ac.uk.
Kerry HoodSouth East Wales Trials Unit (SEWTU), School of Medicine, Cardiff University, Cardiff, UK. HoodK1@cardiff.ac.uk.
Trudie LangThe Global Health Network, Oxford University Centre for Tropical Medicine, University of Oxford, Oxford, UK. trudie.lang@ndm.ox.ac.uk.
Roberta LittlefordTayside Clinical Trials Unit, University of Dundee, Dundee, UK. R.Littleford@dundee.ac.uk.
Kirsty LoudonHealth Services Research Unit, University of Aberdeen, Aberdeen, AB25 2ZD, UK. kirsty.loudon@abdn.ac.uk.
Alison McDonaldHealth Services Research Unit, University of Aberdeen, Aberdeen, AB25 2ZD, UK. a.mcdonald@abdn.ac.uk.
Gladys McPhersonHealth Services Research Unit, University of Aberdeen, Aberdeen, AB25 2ZD, UK. g.mcpherson@abdn.ac.uk.
Annmarie NelsonMarie Curie Palliative Care Research Centre, Cardiff University School of Medicine, Heath Park, Cardiff, Wales, CF14 4YS, UK. nelsona9@cardiff.ac.uk.
John NorrieHealth Services Research Unit, University of Aberdeen, Aberdeen, AB25 2ZD, UK. j.norrie@abdn.ac.uk.
Craig RamsayHealth Services Research Unit, University of Aberdeen, Aberdeen, AB25 2ZD, UK. c.r.ramsay@abdn.ac.uk.
Peter SandercockDivision of Clinical Neurosciences, The University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, UK. Peter.Sandercock@ed.ac.uk.
Daniel R ShanahanBioMed Central Ltd, 236 Gray's Inn Road, London, WC1X 8HB, UK. Daniel.Shanahan@biomedcentral.com.
William SummerskillThe Lancet, London, UK. Bill.Summerskill@lancet.com.
Matt SydesMedical Research Council, Clinical Trials Unit (MRC CTU), London, UK. m.sydes@ucl.ac.uk.
Paula WilliamsonNorth West Hub for Trials Methodology Research and Department of Biostatistics, University of Liverpool, 1st floor Duncan Building Daulby Street, Liverpool, L69 3GA, UK. P.R.Williamson@liverpool.ac.uk.
Mike ClarkeInstitute of Clinical Sciences, Block B, Queens University Belfast, Royal Victoria Hospital, Grosvenor Road, Belfast, BT12 6BA, UK. m.clarke@qub.ac.uk.

Funding

Cancer Research UK 16895Chief Scientist Office HSRU1Chief Scientist Office NMAHP2Chief Scientist Office SPHSU1Marie Curie MCCC-FCO-11-CMedical Research Council G0800803Medical Research Council G0901530Medical Research Council G1002325Medical Research Council MC_UU_12017/15Medical Research Council MC_UU_12017/4Medical Research Council MC_UU_12023/24Medical Research Council MC_UU_12023/25Medical Research Council MR/K023233/1Medical Research Council MR/K025635/1Medical Research Council MR/K025643/1Medical Research Council MR/L004933/1
6 · The paper itself

Abstract

Randomised trials are at the heart of evidence-based healthcare, but the methods and infrastructure for conducting these sometimes complex studies are largely evidence free. Trial Forge ( www.trialforge.org ) is an initiative that aims to increase the evidence base for trial decision making and, in doing so, to improve trial efficiency.This paper summarises a one-day workshop held in Edinburgh on 10 July 2014 to discuss Trial Forge and how to advance this initiative. We first outline the problem of inefficiency in randomised trials and go on to describe Trial Forge. We present participants' views on the processes in the life of a randomised trial that should be covered by Trial Forge.General support existed at the workshop for the Trial Forge approach to increase the evidence base for making randomised trial decisions and for improving trial efficiency. Agreed upon key processes included choosing the right research question; logistical planning for delivery, training of staff, recruitment, and retention; data management and dissemination; and close down. The process of linking to existing initiatives where possible was considered crucial. Trial Forge will not be a guideline or a checklist but a 'go to' website for research on randomised trials methods, with a linked programme of applied methodology research, coupled to an effective evidence-dissemination process. Moreover, it will support an informal network of interested trialists who meet virtually (online) and occasionally in person to build capacity and knowledge in the design and conduct of efficient randomised trials.Some of the resources invested in randomised trials are wasted because of limited evidence upon which to base many aspects of design, conduct, analysis, and reporting of clinical trials. Trial Forge will help to address this lack of evidence.

Indexed as

Efficiency, OrganizationalResearch DesignAccess to InformationCooperative BehaviorEfficiencyEvidence-Based MedicineHumansInformation DisseminationInterdisciplinary CommunicationInternational CooperationRandomized Controlled Trials as Topic

Identifiers

PMID26044814
PMCPMC4475334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.